Gaertner Jan, Appenzeller-Herzog Christian, Piechotta Vanessa, Schwarzer Guido, Rémi Constanze, Suter Katja, Boehlke Christopher
Department of Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
Palliative Care Center, Bethesda Hospital, Basel, Switzerland.
Cochrane Database Syst Rev. 2025 Aug 29;8(8):CD016207. doi: 10.1002/14651858.CD016207.
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of pharmacological treatments given prophylactically or on-demand after onset of opioid-induced nausea and vomiting (OINV) in people being treated for cancer pain or cancer dyspnoea, when compared to placebo or other pharmacological interventions.
这是一项Cochrane系统评价(干预措施)的方案。目标如下:与安慰剂或其他药物干预措施相比,评估在接受癌症疼痛或癌症呼吸困难治疗的患者中,预防性或在阿片类药物引起的恶心和呕吐(OINV)发作后按需给予药物治疗的益处和危害。